Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries

A. M. Mileo, M. Fanuele, F. Battaglia, G. Scambia, C. Benedetti-Panici, E. Mattei, S. Mancuso, A. Delpino

Research output: Contribution to journalArticlepeer-review

Abstract

The HER-2/neu oncogene (a member of the Erb-like oncogene family) is distinct from but closely related to the c-erb B gene which encodes the epidermal growth factor receptor (EGFr). HER-2/neu gene amplification was found in a large number of mammary carcinomas and there was a strong correlation between this phenomenon and poor prognosis. In our study HER-2/neu oncogene expression was determined in 16 malignant ovarian tumors, 2 ovarian lymphomas and 5 normal ovaries. The HER-2/neu gene was found both in normal ovaries and malignant tumors, without any apparent difference among the various histological types. In all the specimens examined, HER-2/neu expression did not seem to be related to EGF binding capacity.

Original languageEnglish
Pages (from-to)114-118
Number of pages5
JournalInternational Journal of Biological Markers
Volume7
Issue number2
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Biochemistry
  • Immunology

Fingerprint Dive into the research topics of 'Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries'. Together they form a unique fingerprint.

Cite this